Vivelle-Dot and Breastfeeding
Before using Vivelle-Dot, breastfeeding women should talk to their healthcare providers about the potential risks. Although the hormone in the medication passes through breast milk, the amounts are probably too low to cause any significant problems in a nursing child. The main concern regarding Vivelle-Dot and breastfeeding is that the hormone can decrease both the quantity and quality of breast milk.
Vivelle-Dot® (estradiol patch) is a prescription hormone replacement medication. As an estrogen medication, it is not recommended for breastfeeding women. Therefore, make sure to check with your healthcare provider before taking Vivelle-Dot if you are breastfeeding.
Estradiol, the hormone in Vivelle-Dot, passes through breast milk. However, it passes through breast milk in amounts that are probably too low to cause significant or long-lasting problems in breastfeeding infants.
Of greater concern, estrogen medications can decrease the quantity and quality of breast milk. It is for this reason that estrogen-containing medications (including Vivelle-Dot) are usually not recommended for women who are breastfeeding.
You should talk with your healthcare provider about Vivelle-Dot and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Vivelle-Dot and breastfeeding that is right for you.